Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China Jama. 2020;323(11):1061–9.

Article  CAS  PubMed  Google Scholar 

Verity R, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rudd KE, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200–11.

Article  PubMed  PubMed Central  Google Scholar 

Eworuke E, Major JM, Gilbert McClain LI. National incidence rates for Acute respiratory distress syndrome (ARDS) and ARDS cause-specific factors in the United States (2006–2014). J Crit Care. 2018;47:192–7.

Article  PubMed  Google Scholar 

Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet. 2021;398(10300):622–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Munshi L, et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med. 2019;7(2):163–72.

Article  PubMed  Google Scholar 

Ma X, et al. Extracorporeal membrane oxygenation (ECMO) in critically Ill patients with coronavirus disease 2019 (COVID-19) pneumonia and acute respiratory distress syndrome (ARDS). Med Sci Monit. 2020;26: e925364.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bernhardt AM, et al. Extracorporeal membrane oxygenation. Dtsch Arztebl Int. 2022;119(13):235–44.

PubMed  Google Scholar 

Combes A, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(21):1965–75.

Article  PubMed  Google Scholar 

Peek GJ, et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res. 2006;6:163.

Article  PubMed  PubMed Central  Google Scholar 

Mehta P, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Root-Bernstein R. Innate receptor activation patterns involving TLR and NLR synergisms in COVID-19, ALI/ARDS and sepsis cytokine storms: a review and model making novel predictions and therapeutic suggestions. Int J Mol Sci. 2021;22(4):2108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, et al. Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan. China Virus Res. 2020;286: 198043.

Article  CAS  PubMed  Google Scholar 

Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250–6.

Article  CAS  PubMed  Google Scholar 

Kim JS, et al. Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics. 2021;11(1):316–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alavi Darazam I, et al. Efficacy of hemoperfusion in severe and critical cases of COVID-19. Blood Purif. 2022;52:1–9.

Google Scholar 

Shadvar K, et al. Hemoperfusion as a potential treatment for critically Ill COVID-19 patients with cytokine storm. Blood Purif. 2021;50(3):405–7.

Article  CAS  PubMed  Google Scholar 

Hashemian SM, et al. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021;27(6):486–92.

Article  PubMed  Google Scholar 

Datzmann T, Träger K. Extracorporeal membrane oxygenation and cytokine adsorption. J Thorac Dis. 2018;10(Suppl 5):S653-s660.

Article  PubMed  PubMed Central  Google Scholar 

Poli EC, Rimmelé T, Schneider AG. Hemoadsorption with CytoSorb(®). Intensive Care Med. 2019;45(2):236–9.

Article  PubMed  Google Scholar 

De Rosa S, et al. Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry. Artif Organs. 2021;45(6):E187-e194.

PubMed  Google Scholar 

Clark WR, et al. Membranes and sorbents. Contrib Nephrol. 2018;194:70–9.

Article  PubMed  Google Scholar 

Pomarè Montin D, et al. Biocompatibility and cytotoxic evaluation of new sorbent cartridges for blood hemoperfusion. Blood Purif. 2018;46(3):187–95.

Article  PubMed  Google Scholar 

Harm S, Schildböck C, Hartmann J. Cytokine removal in extracorporeal blood purification: an in vitro study. Blood Purif. 2020;49(1–2):33–43.

Article  CAS  PubMed  Google Scholar 

Chai Y, et al. Hydroxyapatite reinforced inorganic-organic hybrid nanocomposite as high-performance adsorbents for bilirubin removal in vitro and in pig models. Bioact Mater. 2021;6(12):4772–85.

CAS  PubMed  PubMed Central  Google Scholar 

Chen J, et al. High performance of a unique mesoporous polystyrene-based adsorbent for blood purification. Regen Biomater. 2017;4(1):31–7.

Article  CAS  PubMed  Google Scholar 

Chai Y, et al. Bead-type polystyrene/nano-CaCO(3) (PS/nCaCO(3)) composite: a high-performance adsorbent for the removal of interleukin-6. J Mater Chem B. 2019;7(9):1404–14.

Article  CAS  PubMed  Google Scholar 

Cao W. Blood purification in a critically ill COVID-19 patient with cytokine storm: a case report. J Am Soc Nephrol. 2021;32:104.

Google Scholar 

Jang JH, et al. Acute respiratory distress syndrome caused by carbon monoxide poisoning and inhalation injury recovered after extracorporeal membrane oxygenation along with direct hemoperfusion with polymyxin B-immobilized fiber column: a case report. J Med Case Rep. 2021;15(1):456.

Article  PubMed  PubMed Central  Google Scholar 

Lees NJ, et al. Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to panton-valentine leukocidin-positive Staphylococcus aureus pneumonia and H1N1. J Artif Organs. 2016;19(4):399–402.

Article  CAS  PubMed  Google Scholar 

Kogelmann K, et al. Use of hemoadsorption in sepsis-associated ECMO-dependent severe ARDS: a case series. J Intensive Care Soc. 2020;21(2):183–90.

Article  PubMed  Google Scholar 

Geraci TC, et al. Hemoadsorption for management of patients on veno-venous ECMO support for severe COVID-19 acute respiratory distress syndrome. J Card Surg. 2021;36(11):4256–64.

Article  PubMed  PubMed Central  Google Scholar 

Ahmad YR, Neyra JA, Ayach T. Hemoperfusion with seraph® filter late in the course of severe COVID-19 pneumonia. J Am Soc Nephrol. 2021;32:104.

Google Scholar 

Supady A, et al. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021;9(7):755–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Badulak J, et al. Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization. Asaio J. 2021;67(5):485–95.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.

Article  PubMed  PubMed Central  Google Scholar 

Iorio A, et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ. 2015;350: h870.

Article  PubMed  Google Scholar 

Akil A, et al. Combined use of CytoSorb and ECMO in patients with severe pneumogenic sepsis. Thorac Cardiovasc Surg. 2021;69(3):246–51.

Article  PubMed  Google Scholar 

Akil A, et al. Blood purification therapy in patients with severe COVID-19 requiring veno-venous ECMO therapy: a retrospective study. Int J Artif Organs. 2022;45(7):615–22.

Article  CAS  PubMed